Thibault C, Laury M C, Bailbe D, Ktorza A, Portha B
Laboratoire de Physiopathologie de la Nutrition, CNRS URA 307, Université Paris 7, France.
Endocrinology. 1992 May;130(5):2521-7. doi: 10.1210/endo.130.5.1572279.
This work was designed to investigate the effect of an additional hyperglycemia on the subsequent in vivo insulin secretion in rats with various degrees of glucose intolerance. Four groups of rats received a unique injection of a low concentration of streptozotocin (STZ): 20, 27, 30, or 35 mg/kg corresponding, respectively, to STZ 20, STZ 27, STZ 30, or STZ 35 rats. Control rats were injected with citrate buffer. In all STZ groups, impaired glucose tolerance and insulin secretion were observed. These defects were roughly proportional to STZ concentration. Three weeks after STZ administration, hyperglycemia (17 mM) was produced by a 48-h glucose infusion via an indwelling catheter. Insulin secretion in response to glucose was investigated 3 h after stopping glucose infusion, by performing iv glucose tolerance tests. Insulin secretion in response to glucose doubled in control rats previously submitted to glucose infusion, and still more in rats with mild glucose intolerance (three and four times higher in STZ 20 and STZ 27 rats, respectively). By contrast, glucose infusion increased insulin secretion only slightly in STZ 30 rats and it was unchanged in STZ 35 rats. These data show that prolonged hyperglycemia has an improving effect on insulin secretion in rats with mild glucose intolerance, whereas the potentiating effect of previous hyperglycemia is lost in rats with more severe glucose intolerance.
本研究旨在探讨额外的高血糖对不同程度葡萄糖不耐受大鼠随后体内胰岛素分泌的影响。四组大鼠分别接受低浓度链脲佐菌素(STZ)的单次注射:20、27、30或35 mg/kg,分别对应STZ 20、STZ 27、STZ 30或STZ 35大鼠。对照大鼠注射柠檬酸盐缓冲液。在所有STZ组中,均观察到葡萄糖耐量和胰岛素分泌受损。这些缺陷与STZ浓度大致成正比。STZ给药三周后,通过留置导管进行48小时葡萄糖输注产生高血糖(17 mM)。在停止葡萄糖输注3小时后,通过进行静脉葡萄糖耐量试验来研究对葡萄糖的胰岛素分泌。先前接受葡萄糖输注的对照大鼠对葡萄糖的胰岛素分泌增加了一倍,轻度葡萄糖不耐受的大鼠增加得更多(STZ 20和STZ 27大鼠分别高出三到四倍)。相比之下,葡萄糖输注仅使STZ 30大鼠的胰岛素分泌略有增加,而STZ 35大鼠的胰岛素分泌没有变化。这些数据表明,长期高血糖对轻度葡萄糖不耐受大鼠的胰岛素分泌有改善作用,而先前高血糖的增强作用在更严重葡萄糖不耐受的大鼠中丧失。